The aim of this study was to establish whether cytotoxic T cells (Tc), raised against respiratory syncytial virus (RSV) in the mouse, are specific to the strain of immunizing virus, or cross-reactive between virus strains. Several recent studies using monoclonal antibodies have begun to define the antigenic variation among strains of RSV. It is likely that a successful RSV vaccine will need to contain antigenic determinants from more than one subtype, but since only the highest levels of neutralizing antibody are able to give complete protection against RSV infection, a vaccine may also need to elicit a cellular immune response. We have recently described H-2-restricted, RSVspecific Tc following RSV infection in the mouse; we present here evidence that polyclonal RSV-specific Tc in the mouse recognize syngeneic target cells infected with every human strain of RSV tested, whatever the subtype. The only RSV strain that appeared not to be recognized was bovine RSV, which seems unable to infect mouse cells; however, bovine cells, infected with bovine RSV and fixed with glutaraldehyde, primed mice for Tc which recognized human strains of RSV. 
INTRODUCTION
The importance of the antigenic heterogeneity of respiratory syncytial virus (RSV) in natural infection is little understood. In the 1960s it was shown that the extent of this heterogeneity is small compared with some viruses, for example influenza virus, but it was then shown by cross-neutralization assays (Coates & Chanock, 1962; Coates et al., 1963; Doggett & TaylorRobinson, 1965 ) and reciprocal plaque reduction assays (Coates et al., 1966 ) that antigenic differences could be identified between RSV strains.
Recent studies using monoclonal antibodies to human RSV have identified two (Gimenez et al., 1984; Stott et al., 1984a; Ward et al., 1984; Mufson et al., 1985) or three (Anderson et al., 1985) distinct antigenic groups. While these respective authors examined many different virus isolates, the studies concur in grouping the Long and A2 strains (with other early strains) separately from the 8/60, 18537 and RSN-2 strains, although Anderson et al. (1985) were able to define further antigenic differences between the A2 (and A1) strains and the Long strain. In this paper, we shall use the designation of Anderson et al. (see Table 1 ) of groups (subtypes) 1 to 3.
Although passively transferred antibody gives some protection against RSV infection (Parrott et al., 1973 ; Downham et al., 1976; Walsh et al., 1984; Taylor et al., 1984) , high antibody levels are required for complete protection (Prince et al., 1985) , and immunity is only gradually acquired in infants after repeated infections with the virus (Glezen et al., 1981) . Also, reinfection by the same strain can occur in the face of neutralizing antibody (Coates et al., 1963; Beem, 1967; Henderson et al., 1979) . A successful vaccine may, therefore, need to elicit a cellular immune response to RSV in addition to antibody; there is evidence in man (Fishaut et al., 1979) , cotton rats (Sun et al., 1983) and mice (M. J. Cannon & E. J. Stott, unpublished observations) that cell-mediated immunity plays a part in combating RSV infection. We have recently t Present address: Nuffield Department of Clinical Medicine, Job.n Radcliffe Hospital, Oxford OX3 9DU, U.K. 0000-6943 O 1986 SGM described the generation in mice of RSV-specific, major histocompatibility complex-(MHC)-restricted cytotoxic T cells (Tc) (Bangham et al., 1985) . In view of the antigenic subtypes now identified among RSV strains, it is important to ascertain whether these Tc are cross-reactive, i.e. whether Tc raised against one RSV subtype recognize strains of the other subtype(s). We show here that there is indeed qualitative cross-reaction, which is apparently complete, between the three antigenic subtypes of human RSV identified by Anderson et al. (1985) .
METHODS

Mice.
Female BALB/c mice (aged 1 to 3 months) were obtained from the specific pathogen-free colony bred at the National Institute for Medical Research.
Virus; plaque assay. The A2, Randall, 8/60, 18537 and bovine 127 strains of RSV were given by E. J. Stott (Institute for Research on Animal Diseases, Compton, U.K.). The RSS-2 and RSN-2 strains were given by Professor C. R. Pringle (University of Warwick, Covent~, U.K.). Each strain was grown in HEp-2 cells in H21 (DMEM) medium with 10% foetal calf serum (FCS), penicillin (60 l.tg/ml), streptomycin (100 p.g/ml) and glutamine (300 ~tg/ml), harvested at 72 h after infection (120 h in the case of the 18537 strain), and stored without clarification in 1 ml aliquots in liquid nitrogen. Table 1 shows the origin of these strains, and their classification by Anderson et al. (1985) . The plaque assay was done on monolayers of HEp-2 cells, incubated for 5 days at 33 °C with an overlay containing 0.25 % agaruse, as described previously (Bangham et al., 1985) . Bovine nasal mucosa cells infected with bovine RSV (Compton 127 strain) and fixed with 0.075% glutaraldehyde (Stott et al., 1984b) were supplied by E. J. Stott.
Immunization of mice. Mice were given 50 ~tl intranasally (i.n .) of a 1 : 5 dilution of stock virus (A2 or 8/60 strains; equivalent to 2 x 105 p.f.u.) in phosphate-buffered saline (PBS-A), under pentobarbitone anaesthesia [30 mg/kg intraperitoneally (i.p.)]. BCH4 cells (see Target cells below), fixed with 0.075 % glutaraldehyde for 5 rain (obtained from E. J. Stott) were used to immunize mice against the Long strain of RSV: mice were given two doses i.p., each of 105 cells, separated by 3 weeks, with or without 20 ~tg Quil A (a saponin derivative) as adjuvant. Mice immunized against the bovine strain were either given stock 127 strain virus i.n. (as above), or fixed infected bovine nasal mucosa cells using the same regimen as for the fixed BCH4 cells.
Generatmn ofTc. Tc memory cells were derived from the spleens of mice primed 3 to 8 weeks earlier (see above), and re-stimulated in vitro, as described before (Bangham et al., 1985) : briefly, 3 x 106 autologous spleen cells (stimulators) were incubated for I to 2 h at 37 °C with 300 p.1 of stock virus, and then incubated for 5 days at 37 °C with 1.5 x 107 spleen cells (responders) in 20 ml RPMI 1640 medium with 10% FCS, and antibiotics and glutamine as above. The virus strain used to re-stimulate the spleen cells was the same as the priming strain, except that spleen cells from mice primed with fixed BCH4 cells or fixed infected bovine nasal mucosa cells were restimulated with the A2 strain.
Target cells and cytotoxicity assay. A continuous line of BALB/c fibroblasts, and a branch (BCH4) of the same line persistently infected with the Long strain of RSV (Fernie et al., 1981) , were obtained from E. J. Stott. For use as targets in the cytotoxicity assay, BALB/c fibroblasts were incubated with 300 ~tl of stock virus (a multiplicity of infection of 0.1 to I p.f.u./cell) for 90 rain at 37 °C, then incubated in a 6 cm diam. Petri dish (Nunc) in RPMI 1640 medium with 10% FCS, antibiotics and glutamine as above, for 2 days, or 6 days in the case of the 18537 strain. Tc were assayed by a chromium release assay, as previously described (Bangham et al., 1985) 
RESULTS
RSV cross-reaction of Tc raised against A2 or 8/60 strains
The Tc prepared from mice immunized with the 8/60 strain of RSV recognized BALB/c fibroblasts infected with every RSV strain tested (Fig. 1) , whatever its antigenic subtype (Table  1) . The same target cells were lysed by Tc from mice primed with A2 strain RSV (re-stimulated with the A2 strain in vitro), with approximately the same rank order of percentage specific lysis (Fig. 2) . The differences in lysis between different virus strains, at a given effector : target (E : T) ratio, do not necessarily reflect antigenic variation among the target virus strains (see Discussion), since the strains differed in titre (Table 1) , in growth rate (Coates et al., 1966) , and possibly in infectivity.
The 18537 strain, which grew considerably more slowly in culture than any other strain used here, produced no c.p.e, in the BALB/c fibroblasts at 2 days post-infection, and the fibroblasts (Stott et al., 1984b) ; all other strains were assayed as described in Methods.
* Not assigned by Anderson et aL (see Results).
:~ Long strain used only in fixed infected cells in this study (see Methods).
were not lysed when used in a cytotoxicity assay at this time. These target cells were therefore incubated for 5 or 6 days before use in the cytotoxicity assay, when the cells showed extensive c.p.e. Fig. 3 shows that these targets were then recognized and lysed by Tc from mice inoculated i.n. with the A2 strain; Tc raised against the 8/60 strain lysed these targets with equal efficiency (not shown).
Priming for memory Tc by glutaraldehyde-fixed, infected cells
That Tc from mice immunized with Long strain RSV recognized the A2 strain is shown in Fig. 4 . These mice were given glutaraldehyde-fixed BCH4 cells i.p. as described under Methods.
Their spleens were removed 3 weeks after the second dose, and the spleen cells re-stimulated in C. R. M. BANGHAM AND B. A. ASKONAS vitro with A2 strain RSV; this re-stimulation was, of course, likely to select for Tc cross-reacting between the Long and A2 strains. Neither a second dose of cells, nor Quil A adjuvant, was essential to elicit these Tc; this regimen was used because it also induces an effective secondary antibody response (Stott et al., 1984b) . This finding complemented our earlier, converse observation (Bangham et al., 1985) , in which Tc raised against the A2 strain recognized the Long strain.
Bovine RS V primed for RS V cross-reactive memory To, but failed to form a target for Tc
Fig. 4 also shows that BALB/c mice given two i.p. doses of glutaraldehyde-fixed bovine nasal mucosa cells, infected before fixation with bovine 127 strain RSV, induced Tc memory cells which recognized BCH4 target cells (which carry the Long strain of RSV). This induction was approximately as efficient as induction of Tc by the fixed BCH4 cells. Again, these Tc precursors were re-stimulated in vitro using the A2 strain: however, 5 days in vitro was too short for a primary Tc response to RSV to develop, and so this RSV-specific response was evidence of epitope sharing between human and bovine strains. E. J. Stott (personal communication) groups the bovine RSV strains with the human 8/60, RSN-2 and 18537 strains, i.e. group 2 of Anderson et al. (1985) . Thus, in these experiments, Tc raised against a group 2 (bovine 127) strain, restimulated by a group 3 strain (A2), recognized cells infected with a group 1 strain (Long).
Despite the cross-reactivity shown above, it was not possible to prime BALB/c mice i.n. with bovine 127 strain RSV: mice inoculated in this way did not develop any Tc activity against BCH4 targets (results not illustrated). In addition, BALB/c fibroblasts infected for 2 days in vitro with the bovine 127 strain, at 33 °C (the permissive temperature for this strain), failed both to show any c.p.e, and to form a target for Tc raised against the A2 strain (not illustrated). However, the bovine 127 strain was able to induce Tc which recognized cells infected with human strains of RSV (Fig. 4) . These results therefore demonstrate that, within the limits of this study, polyclonal anti-RSV Tc do not discriminate between antigenic subtypes of RSV.
DISCUSSION
The recent studies using monoclonal antibodies to group RSV strains into subtypes (see Introduction for references) have extended the early observations made with hyperimmune polyclonal antisera, of antigenic differences between certain strains of RSV. It seems clear that the main serological differences lie between two groups, group A of Mufson et al. (1985) (groups 1 and 3 of Anderson et al., 1985) , and Mufson's group B (group 2 of Anderson et al.) . Mufson et ak used a competition ELISA to identify epitopes on the different virus strains tested, and they found that the greatest difference between groups A and B was in the G protein, where five of the six epitopes identified were distinct. They concluded, from the extent of this difference, that these two antigenic subtypes separated in evolution relatively early, and that G proteins from representatives of both their groups A and B may be necessary in an effective RSV vaccine. Anderson et al. (1985) divided the first subtype further, separating the Australian isolates A 1 and A2 on the basis of their reaction with two monoclonal antibodies (one anti-N, one anti-G). However, they concluded that groups 1 and 3 were antigenically similar, and group 2 antigenically more distinct.
It is important to examine the role of T cell immunity to RSV for two main reasons: first, because antibody is incompletely protective (see Introduction), and so an effective vaccine may need to elicit a T cell response; second, because the paradoxically severe RSV infection seen in some infants who had previously received the formalin-inactivated vaccine (in the 1960s) may have been due to damage by a cellular effector mechanism (McIntosh & Fishaut, 1980; Karzon, 1983) . The characteristics of the T cells elicited by a potential RSV vaccine must therefore be known.
We have recently shown that RSV-specific Tc cells can be elicited in mice by live or u.v.-inactivated RSV (Bangham et al., 1985) . Work is in progress to determine whether these Tc cells limit the replication of RSV in the mouse's lung. In the present paper, we show that mixed (polyclonal) Tc from mice primed i.n. (and re-stimulated in vitro) with either A2 (group 3) or 8/60 (group 2) strains recognize all of the virus strains tested, including strains from each of the three antigenic groups. And mice primed with Long strain RSV (in the form of glutaraldehyde-fixed BCH4 cells) recognized the A2 strain (other viruses not tested here as targets). These observations parallel those made on (for example) influenza virus, where polyclonal Tc do not distinguish between the serologically distinct type A strains (Zweerink et al., 1977) , and confirm our previous finding (Bangham et al., 1985) of Tc cross-reaction between different RSV strains, albeit variable in magnitude (as judged by the extent of lysis in the chromium release assay).
The observed RSV cross-reaction of anti-RSV Tc cells, in the face of considerable antigenic differences in the G protein (Mufson et al., 1985) , suggests that the cross-reactive Tc cells recognize either a common site on the G protein distinct from these monoclonal antibody epitopes, or a different, possibly internal viral antigen(s), as appears to be the case in influenza virus (Townsend & Skehel, 1984) , where the nucleoprotein serves as a major cross-reactive determinant for Tc. Possible target antigens for cross-reactive Tc include the F (fusion) and 22K proteins of RSV, both of which are associated with the membrane of infected cells. It is probable that Tc cell clones could be selected which would be specific to certain strains of RSV, but whether the use of such clones would provide the same subtype classification as that provided by monoclonal antibodies is a matter for speculation.
Quantitative differences between strains in this recognition (i.e. differences in percentage specific lysis at a given E : T ratio) do not necessarily imply only partial cross-reaction; since the virus strains differ in their titre, plaque morphology, c.p.e, and rate of growth (Coates et al., 1966) , the extent of infection or even the pattern of surface antigen expression could vary from one strain to another. The clearest example of this seen in the present study was the 18537 strain, which was found to grow slowly both in ferrets (Coates et aL, 1963) and in vitro (Coates et al., 1966) ; we observed no c.p.e, until 4 days post-infection, and there was no specific lysis of BALB/c fibroblast targets infected with this strain for only 48 h, which was sufficient for target formation for all other human strains examined here.
There was no simple relation between the titre of virus used to infect targets and the percentage specific lysis; for example, targets infected with the Randall strain (logio p.f.u, titre 5.5) and those infected with the RSS-2 strain (logto p.f.u, titre 7.1) were lysed to a similar extent by Tc raised against either the 8/60 strain (Fig. 1) or the A2 strain (Fig. 2) . This similarity suggests a close antigenic relationship between the Randall and RSS-2 strains, but this cannot be definitely concluded from the present data, for the reasons given above.
The extent of the cross-reaction is emphasized by the experiments (Fig. 4) These results indicate that, as with influenza-specific Tc, polyclonal anti-RSV Tc recognize different subtypes of the virus.
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